Project 2: The Intersection of Telehealth and Health Disparities in At-Risk Older Patients with Cancer
项目 2:远程医疗与高危老年癌症患者健康差异的交叉点
基本信息
- 批准号:10762145
- 负责人:
- 金额:$ 24.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-19 至 2028-08-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdverse eventCOVID-19 pandemicCaliforniaCancer PatientCaringCatchment AreaCohort StudiesCommunicationComplementCountyDataData SetDatabasesDevelopmentDisparityElderlyEmergency department visitEnvironmentEquityEthnic OriginFutureHealth Services AccessibilityHealth systemHealthcareHealthcare SystemsHospitalizationHospitalsHouseholdImprove AccessIncomeIndividualInequalityInequityInternetInterventionKnowledgeLanguageLinkLogistic RegressionsLow incomeMalignant NeoplasmsMedicareMedicare claimMedicare/MedicaidMethodsModelingOncologyOutcomePatient CarePatient-Focused OutcomesPatientsPerceptionPersonsPoliciesPolicy MakerPopulationPopulations at RiskPositioning AttributeProviderQuality of CareRaceResearchRiskSafetySecondary toSocioeconomic StatusSurveysTechnologyTelecommunicationsTestingVisitVulnerable Populationsaccess disparitiesadverse outcomeanticancer researchbeneficiarycancer carecancer educationcancer health disparitycancer riskcare deliverycare outcomesdisparity reductionethnic minorityexperiencehealth disparityhealth equityimprovedinterestmarginalized populationneoplasm registryolder patientpandemic diseasepatient populationpatient-level barrierspopulation basedpost-COVID-19provider-level barriersracial minorityresponsetelehealth
项目摘要
PROJECT SUMMARY/ ABSTRACT – PROJECT 2
Telehealth utilization increased rapidly across the US healthcare system in response to the COVID-19
pandemic. As we emerge from the pandemic, telehealth has become a new option for communication between
patients and providers. Cancer care delivery appears well positioned to incorporate telehealth into the standard
workflow of patient care. Furthermore, equitable implementation of telehealth could potentially increase access
to care among vulnerable patients. However, emerging data suggest disparities with telehealth utilization
access among non-White, low income, and non-English speaking individuals. Inequitable implementation of
telehealth could inadvertently create barriers among our most vulnerable patients, which could paradoxically
increase cancer health disparities. Large-scale rigorous research evaluating disparities in telehealth utilization
within the post-COVID-19 cancer care environment is lacking. Furthermore, research has not addressed how
telehealth utilization influences safety and quality of care compared to conventional in-person visits, particularly
among our at-risk populations with higher baseline risks of poor outcomes and adverse events. Finally, a
comprehensive understanding of telehealth disparities requires an understanding of patient perceptions and
provider biases towards telehealth, which represent important unaddressed questions. To fill these critical
knowledge gaps, we propose a comprehensive population-based cohort study among Medicare beneficiaries
with cancer, incorporating linkages to secondary datasets providing data on providers, hospitals, and regional
factors. We will assess the impact of telehealth on vulnerable cancer populations through the following aims: 1)
identify and characterize disparities in telehealth during and after the COVID-19 pandemic; 2) assess the
impact of telehealth on efficacy and safety of cancer delivery among at-risk populations; and 3) define
actionable patient-level barriers and provider biases with telehealth utilization. This proposed study will help
define the national landscape of telehealth among cancer patients, and will provide a framework for the
development of future interventions to optimize telehealth among at-risk patients. This timely project will deliver
actionable information to providers, healthcare systems, and policymakers. Overall, equitable, safe, and
effective telehealth delivery stands to increase access to care and reduce cancer health disparities among our
most vulnerable cancer patients.
项目总结/摘要-项目2
为应对COVID-19,美国医疗系统的远程医疗利用率迅速增长
流行病随着我们摆脱这一流行病,远程保健已成为人们之间交流的一种新选择,
患者和供应商。癌症护理提供似乎很好地定位,将远程保健纳入标准
病人护理的工作流程。此外,公平实施远程保健有可能增加获得服务的机会
照顾脆弱的病人。然而,新出现的数据表明,远程保健利用率存在差异
在非白人、低收入和非英语国家的人中使用。不公平地执行
远程医疗可能会无意中在我们最脆弱的患者中制造障碍,这可能是矛盾的,
增加癌症健康差距。大规模严格的研究评估远程保健利用的差异
在COVID-19后的癌症护理环境中缺乏。此外,研究还没有解决如何
与传统的面对面访问相比,远程保健的使用影响了护理的安全性和质量,
在我们的高危人群中,不良结局和不良事件的基线风险较高。最后
要全面了解远程医疗的差异,就需要了解患者的看法,
提供者偏向远程保健,这是尚未解决的重要问题。为了填补这些关键的
知识差距,我们建议在医疗保险受益人中进行一项全面的基于人群的队列研究
与癌症,纳入链接到二级数据集提供数据的供应商,医院,
因素我们将通过以下目标评估远程医疗对弱势癌症人群的影响:
识别和描述COVID-19大流行期间和之后远程医疗的差异; 2)评估
远程保健对高危人群中癌症治疗的有效性和安全性的影响;以及3)定义
可采取行动的病人一级的障碍和提供者的偏见与远程保健的利用。这项研究将有助于
定义癌症患者远程医疗的国家格局,并将为
制定未来的干预措施,以优化高危患者的远程保健。这个及时的项目将提供
为提供者、医疗保健系统和决策者提供可操作的信息。总体而言,公平,安全,
有效的远程保健服务将增加获得护理的机会,减少我们之间的癌症健康差距。
最脆弱的癌症患者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Melody K Schiaffino其他文献
Melody K Schiaffino的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Melody K Schiaffino', 18)}}的其他基金
Improving age-related risk assessment and documentation for diverse older adults with cancer
改善不同老年癌症患者的年龄相关风险评估和记录
- 批准号:
10371440 - 财政年份:2022
- 资助金额:
$ 24.45万 - 项目类别:
Improving age-related risk assessment and documentation for diverse older adults with cancer
改善不同老年癌症患者的年龄相关风险评估和记录
- 批准号:
10581662 - 财政年份:2022
- 资助金额:
$ 24.45万 - 项目类别:
相似海外基金
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10707830 - 财政年份:2023
- 资助金额:
$ 24.45万 - 项目类别:
Hospital characteristics and Adverse event Rate Measurements (HARM) Evaluated over 21 years.
医院特征和不良事件发生率测量 (HARM) 经过 21 年的评估。
- 批准号:
479728 - 财政年份:2023
- 资助金额:
$ 24.45万 - 项目类别:
Operating Grants
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
分析 ECOG-ACRIN 不良事件数据,以优化在不断发展的癌症治疗范式 (EVOLV) 背景下纵向耐受性评估的策略
- 批准号:
10884567 - 财政年份:2023
- 资助金额:
$ 24.45万 - 项目类别:
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
AE2Vec:用于自动不良事件检测的医学概念嵌入和时间序列分析
- 批准号:
10751964 - 财政年份:2023
- 资助金额:
$ 24.45万 - 项目类别:
Understanding the real-world adverse event risks of novel biosimilar drugs
了解新型生物仿制药的现实不良事件风险
- 批准号:
486321 - 财政年份:2022
- 资助金额:
$ 24.45万 - 项目类别:
Studentship Programs
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10676786 - 财政年份:2022
- 资助金额:
$ 24.45万 - 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10440970 - 财政年份:2022
- 资助金额:
$ 24.45万 - 项目类别:
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
改进肿瘤学合作组试验的不良事件报告
- 批准号:
10642998 - 财政年份:2022
- 资助金额:
$ 24.45万 - 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10482465 - 财政年份:2022
- 资助金额:
$ 24.45万 - 项目类别:
Expanding and Scaling Two-way Texting to Reduce Unnecessary Follow-Up and Improve Adverse Event Identification Among Voluntary Medical Male Circumcision Clients in the Republic of South Africa
扩大和扩大双向短信,以减少南非共和国自愿医疗男性包皮环切术客户中不必要的后续行动并改善不良事件识别
- 批准号:
10191053 - 财政年份:2020
- 资助金额:
$ 24.45万 - 项目类别: